Inve US ▾
HTHTGC

Hercules Capital (HTGC) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Financials· Jul 30, 2026

Source: earnings call transcript

Executive summary

Hercules Capital Q2 FY26 — Record Operating Performance and Robust Originations

Hercules Capital delivered record operating performance in Q2 FY26, driven by robust originations and fundings, and strong net investment income coverage of its dividend. The company's diversified portfolio and growing private credit funds business contributed to managing $6.1 billion in assets. While credit quality remained stable overall, with a slight increase in lower-rated credits, the firm maintains a disciplined underwriting approach and strong liquidity to capitalize on market opportunities.

Highlights

5
  • Record originations of $2.74 billion for H1 2026, an increase of 35.6% year-over-year.

  • Record fundings of $1.35 billion for H1 2026, an increase of 8.5% year-over-year.

  • Net investment income covered the base shareholder distribution by 125% and the full distribution by 106%.

  • Managed assets grew to approximately $6.1 billion, an increase of 14.4% from a year ago.

  • Portfolio companies raised a record $5.7 billion in new capital in Q2, totaling $9.3 billion YTD.

Concerns

4
  • Weighted average internal credit rating slightly increased to 2.17 from 2.11 in Q1.

  • Grade 4 credits increased to 1.8% from 0.8% in Q1.

  • The number of companies with loans on nonaccrual increased by 1 to 2 loans.

  • M&A valuations and process timing are less certain in certain parts of the market.

Guidance & targets

CategoryTargetConfidence
Prepayment activity
$200 million to $300 million
medium materiality
Medium
Core yield
11.8% and 12%
high materiality
High
Gross SG&A expenses
$25 million to $26 million
medium materiality
High
RIA expense allocation
approximately $4.7 million
low materiality
High
Quarterly dividend from RIA
approximately $2 million to $2.5 million
low materiality
High
Originations
seasonally lower
medium materiality
High
M&A exit activity
continue at these levels
medium materiality
Medium
Interest expense
broadly stable or up slightly
medium materiality
High

Risks & headwinds

General market volatility Ongoing

period of general volatility

Mitigation:Disciplined and conservative new underwriting, maintaining strong and flexible balance sheet, proactive credit management.

M&A valuations and process timing uncertainty over the coming quarters

less certain

Mitigation:Continued monitoring.

Aggressive deal structures from other lenders Recent

a handful of lenders, both bank and nonbank, are being very aggressive in terms of deal structures

Mitigation:Will monitor, but decision is to stay disciplined and not chase the market.

Capital concentration in AI H1 2026

AI defines the venture landscape, capturing nearly 86% of all first half 2026 deal value.

Mitigation:Intentional portfolio diversification with 50% in life sciences and 50% in technology; no single subsector more than 25%.

Increased number of companies seeking debt capital that do not meet quality standards Current

a larger number of companies right now that are in the market that are looking to raise debt capital that we don't think meet the type of quality new underwritings that we're looking for.

Mitigation:Laser-focused on funding only deals that meet quality requirements.

What to watch in Q3 FY26

Prepayment activity

Q3 FY26
Current $572.1 million in Q2 FY26
Target $200 million to $300 million

Why it matters

Prepayments significantly impact investment income and capital redeployment opportunities.

For Q3 2026, we expect prepayments to normalize and be in the range of $200 million to $300 million, although this could change as we progress in the quarter.

Find out whether HTGC delivers this. Inve re-checks your case every morning.

Q&A highlights

Asked about the deployment backdrop, appetite for venture debt, and expected seasonal slowdown in Q3, especially August.

Management expects Q3 to be seasonally lower but still robust. The market is very robust with a strong pipeline, but the focus is on disciplined funding of high-quality deals.

“We do expect Q3 as it typically is to be seasonally lower than our other quarters in terms of capital deployment. Having said that, we still expect a pretty robust Q3 in terms of new originations.”

asked by Crispin Love · answered by Scott Bluestein

2 min read 6 chapters

Detailed narrative

Record Originations and Fundings

Hercules Capital achieved record originations of $2.74 billion and fundings of $1.35 billion in the first half of 2026, representing year-over-year increases of 35.6% and 8.5%, respectively. This activity drove record total investment income and net investment income for the period, demonstrating the platform's ability to deploy capital effectively in a dynamic market.

Portfolio Diversification and Credit Stability

The investment portfolio remains intentionally diversified, with approximately 50% in life sciences and 50% in technology, and no single subsector exceeding 25% of total investments. Credit quality was stable, with weighted average internal credit rating at 2.17, and rated 4 and 5 credits comprising less than 2% of fair value, indicating prudent risk management.

RIA Business Contribution

The wholly-owned private credit fund business, Hercules Adviser, now manages nearly $2 billion in committed capital and provided $7 million in NII contribution to the BDC in Q2, a 26% increase YoY. This segment offers a consistent, reoccurring income stream and enhances the overall platform's capital flexibility and investment capacity.

AI Governance and Technology Investments

Hercules has formalized an internal AI governance committee to oversee the use of AI, ensuring data protection and responsible application. Recent technology investments, including CRM and portfolio management system upgrades, aim to improve efficiency, automation, and real-time data access, supporting the scalable growth of the business.

Strong Portfolio Company Capital Raising

Portfolio companies raised a record $5.7 billion in new capital in Q2, contributing to a year-to-date total of $9.3 billion, surpassing all of 2025. This robust capital raising activity, with a healthy mix between technology (60%) and life sciences (40%), indicates strong investor confidence in Hercules' portfolio companies despite broader market volatility.

Liquidity and Capital Structure

The company ended Q2 with $652.9 million of available liquidity in the BDC, and over $1 billion for the entire Hercules platform. Post-quarter, an additional $325 million of unsecured notes were issued, further strengthening liquidity and positioning the firm to capitalize on attractive capital deployment opportunities.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.